Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults

Abstract

CONTEXT: Chitosan, a deacetylated chitin, is a widely available dietary supplement purported to decrease body weight and serum lipids through gastrointestinal fat binding. Although evaluated in a number of trials, its efficacy remains in dispute.

OBJECTIVE: To evaluate the efficacy of chitosan for weight loss in overweight and obese adults.

DESIGN AND SETTING: A 24-week randomised, double-blind, placebo-controlled trial, conducted at the University of Auckland between November 2001 and December 2002.

PARTICIPANTS: A total of 250 participants (82% women; mean (s.d.) body mass index, 35.5 (5.1) kg/m2; mean age, 48 (12) y)

INTERVENTIONS: Participants were randomly assigned to receive 3 g chitosan/day (n=125) or placebo (n=125). All participants received standardised dietary and lifestyle advice for weight loss. Adherence was monitored by capsule counts.

MAIN OUTCOME MEASURES: The primary outcome measure was change in body weight. Secondary outcomes included changes in body mass index, waist circumference, body fat percentage, blood pressure, serum lipids, plasma glucose, fat-soluble vitamins, faecal fat, and health-related quality of life.

RESULTS: In an intention-to-treat analysis with the last observation carried forward, the chitosan group lost more body weight than the placebo group (mean (s.e.), −0.4 (0.2) kg (0.4% loss) vs +0.2 (0.2) kg (0.2% gain), P=0.03) during the 24-week intervention, but effects were small. Similar small changes occurred in circulating total and LDL cholesterol, and glucose (P<0.01). There were no significant differences between groups for any of the other measured outcomes.

CONCLUSION: In this 24-week trial, chitosan treatment did not result in a clinically significant loss of body weight compared with placebo.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1
Figure 2
Figure 3

References

  1. Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Fukuda N, Hasegawa Y . A novel use of chitosan as a hypocholesterolemic agent in rats. Am J Clin Nutr 1980; 33: 787–793.

    CAS  Article  Google Scholar 

  2. Zacour AC, Silva ME, Cecon PR, Bambirra EA, Vieira EC . Effect of dietary chiton on cholesterol absorption and metabolism in rats. J Nutr Sci Vitaminol 1992; 38: 609–613.

    CAS  Article  Google Scholar 

  3. Deuchi K, Kanauchi O, Imasato Y, Kobayashi E . Effect of the viscosity or deacetylation degree of chitosan on fecal fat excreted from rats fed on a high fat diet. Biosci Biotech Biochem 1995; 59: 781–785.

    CAS  Article  Google Scholar 

  4. Nagyvary JJ, Falk JD, Hill ML, Schmidt ML, Wilkins AK, Brdbury EL . The hypolipidemic activity of chitosan and other polysaccharides in rats. Nutr Rep Int 1979; 30: 677–684.

    Google Scholar 

  5. Ormrod DJ, Holmes CC, Miller TE . Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 1998; 138: 329–334.

    CAS  Article  Google Scholar 

  6. Schiller RN, Barrager E, Schauss AG, Nichols EJ . A randomized, double-blind, placebo-controlled study examining the effects of a rapidly soluble Chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. J Am Nutraceut Assoc 2001; 4: 42–49.

    Google Scholar 

  7. Zahorska-Markiewicz B, Krotkiewski M, Olszanecka-Glinianowicz M, Zurakowski A . Effect of chitosan in the complex treatment of obesity. Polish Med J 2002; 74: 129–132.

    Google Scholar 

  8. Ernst E, Pittler MH . Chitosan as a treatment for body weight reduction? A meta-analysis. Perfusion 1998; 11: 461–465.

    Google Scholar 

  9. Ho SC, Tai ES, Eng PHK, Tan CE, Fok ACK . In the absence of dietary surveillance, Chitosan does not reduce plasma lipids or obesity in hypercholesterolaemic obese Asian subjects. Sing Med J 2001; 42: 6–10.

    CAS  Google Scholar 

  10. Pittler MH, Abbot NC, Harkness EF, Ernst E . Randomized, double-blind trial of chitosan for body weight reduction. Eur J Clin Nutr 1999; 53: 379–381.

    CAS  Article  Google Scholar 

  11. Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB . Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr 2001; 41: 1–28.

    CAS  Article  Google Scholar 

  12. Egger G, Cameron-Smith D, Stanton R . The effectiveness of popular, non-prescription weight loss supplements. Med J Austr 1999; 171: 604–608.

    CAS  Google Scholar 

  13. Russell DG, Wilson NC . Life in New Zealand Commission Report, Volume 1: Executive overview. University of Otago: Dunedin; 1991.

    Google Scholar 

  14. Ware JE, Kosinski M, Keller SD . SF-36 physical and mental health summary scales: a users manual, 2nd edn. The Health Institute, New England Medical Centre: Boston, MA; 1994.

    Google Scholar 

  15. Lavik NJ, Clausen SE, Pedersen W . Eating behaviour, drug use, psychopathology and parental bonding in adolescents in Norway. Acta Psychiatr Scand 1991; 84: 387–390.

    CAS  Article  Google Scholar 

  16. Schouten HJA . Planning group sizes in clinical trials with a continuous outcome and repeat measures. Statist Med 1999; 18: 255–264.

    CAS  Article  Google Scholar 

  17. Frison L, Pocock SJ . Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Statist Med 1992; 11: 1685–1704.

    CAS  Article  Google Scholar 

  18. Hand DJ, Crowder MJ . Practical longitudinal data analysis. Chapman and Hall: London; 1996.

    Book  Google Scholar 

  19. Girola M, De Bernardi M, Contos S, Tripodi S, Ventura P, Guarino C, Marletta M . Dose effect in lipid-lowering activity of new dietary integrator (chitosan, garcinia cambogia extract and chrome). Acta Toxicol Ther 1996; 17: 25–40.

    CAS  Google Scholar 

  20. Wuolijoki E, Hirvela T, Ylitalo P . Decrease in serum LDL cholesterol with microcrystalline Chitosan. Methods Findings in Exp Clin Pharmacol 1999; 21: 357–361.

    CAS  Article  Google Scholar 

  21. Bokura H, Kobayashi S . Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2003; 57: 721–725.

    CAS  Article  Google Scholar 

  22. Dunshea-Mooij C, Ni Mhurchu C, Bennett D, Rodgers A . Chitosan for overweight and obesity (Protocol). The Cochrane library, Issue 4. Update Software: Oxford; 2002.

    Google Scholar 

  23. Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R . Comparative evaluation of fecal fat excretion induced by orlistat and chitosan. Obes Res 2001; 9: 364–367.

    CAS  Article  Google Scholar 

  24. Gades MD, Stern JS . Chitosan supplementation and fecal fat excretion in men. Obes Res 2003; 11: 683–688.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This study could not have been conducted without the dedication of Human Nutrition Unit staff (Jane Easton (Study Manager), Santuri Rungan, Chao-Yuan Chen, David Anderson, Laura Gerulitis, Pia Nielson, Jeannette Eis, Cathelijne Reincke, Shannon McCarthy) and staff at the Clinical Trials Research Unit involved in programming (Alex Bormans, Barry Gray, Donovan Marshall, Clark Mills, Colleen Ng, Michael Ng, Jaco van Rooyen), data management (Michelle Barlow, Yvonne Cleverley, Terry Holloway, Daphne Hukui, Amanda Milne, Ellen Rhyno, Marissa Te Whui, Esther Vao, Sandhya Waghulde, Alison Young) and administrative support (Mary Cosson, Deanne Douglas, Sheila Fisher, Elizabeth Hawthorne). We would like to thank our Data Safety and Monitoring Committee (Katrina Sharples and Jim Mann), and we are particularly grateful for the contribution of the 250 ECHO study participants. This was an investigator-initiated study funded predominantly by the Health Research Council of New Zealand. Study treatments and funding for vitamin analyses was provided by Healtheries of New Zealand Ltd. CNM and AR held fellowships from the National Heart Foundation of New Zealand.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to C Ni Mhurchu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mhurchu, C., Poppitt, S., McGill, AT. et al. The effect of the dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int J Obes 28, 1149–1156 (2004). https://doi.org/10.1038/sj.ijo.0802693

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802693

Keywords

  • chitosan
  • body weight
  • serum lipids
  • randomised controlled trial

Further reading

Search

Quick links